|
KBTBD2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.744000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.192600E-01 |
| Normal-vs-Stage2 |
7.942000E-01 |
| Normal-vs-Stage3 |
3.428400E-01 |
| Normal-vs-Stage4 |
6.577800E-01 |
| Stage1-vs-Stage2 |
7.664400E-01 |
| Stage1-vs-Stage3 |
4.226000E-01 |
| Stage1-vs-Stage4 |
7.835000E-01 |
| Stage2-vs-Stage3 |
3.141800E-01 |
| Stage2-vs-Stage4 |
5.854200E-01 |
| Stage3-vs-Stage4 |
7.691600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.264800E-01 |
| Normal-vs-AfricanAmerican |
9.135000E-01 |
| Normal-vs-Asian |
7.681400E-01 |
| Caucasian-vs-AfricanAmerican |
9.362600E-01 |
| Caucasian-vs-Asian |
7.797000E-01 |
| AfricanAmerican-vs-Asian |
7.688600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.826800E-01 |
| Normal-vs-Female |
5.819800E-01 |
| Male-vs-Female |
5.987000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.954800E-01 |
| Normal-vs-Extreme_Weight |
8.875800E-01 |
| Normal-vs-Obese |
7.522400E-01 |
| Normal-vs-Extreme_Obese |
4.077000E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.250600E-01 |
| Normal_Weight-vs-Obese |
3.459000E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.242000E-01 |
| Extreme_Weight-vs-Obese |
8.606200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.277200E-01 |
| Obese-vs-Extreme_Obese |
3.264600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.050200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.246200E-01 |
| Normal-vs-Age(61-80Yrs) |
5.282400E-01 |
| Normal-vs-Age(81-100Yrs) |
2.763800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.510000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.540980E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.563800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.342100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.371900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.171800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.909900E-02 |
| Normal-VS-Type2 PRCC |
1.939840E-03 |
| Normal-VS-KIRP CIMP |
2.611400E-01 |
| Normal-VS-Unclassified PRCC |
9.453600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.6375003009681E-10 |
| Type1 PRCC-VS-KIRP CIMP |
9.876400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.240160E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.241600E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
2.068400E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.101200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.550410E-02 |
| Normal-vs-N1 |
5.548600E-01 |
| Normal-vs-N2 |
6.666600E-01 |
| N0-vs-N1 |
8.417700E-03 |
| N0-vs-N2 |
1.173600E-01 |
| N1-vs-N2 |
9.549600E-01 |
|
|
